12.05.2017: New Application Note on TREK-1 is out!
The latest Application Note from Nanion shows recordings of TREK-1 on the SyncroPatch 384PE.
HEK cells expressing TREK-1 (an excellent cell line from SB Drug Discovery) were used on the SyncroPatch 384PE with a high success rate and BL-1249 and THA were used to activate and inhibit TREK-1, respectively. Read the full allpication note here.